Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208142 · ClinicalTrials.gov registry record · NA
Toe Walker Gait Trial
A NA study, sponsored by Dynasplint Systems.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01208142 is a NA study that was terminated before completion, run by Dynasplint Systems. The registered enrollment target is 10 participants.
The verdict
NCT01208142, a NA study, was terminated before completion, sponsored by Dynasplint Systems.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the change in ankle plantar flexion while walking, following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as Toe Walkers. For twelve weeks, patients will either receive the standard treatment or the same standard treatment and the Dynaslint worn at night.
Interventions
- OTHER standard of care treatment
- DEVICE Ankle Flexion Dynasplint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01208142
The ClinicalTrials.gov registry entry for NCT01208142 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dynasplint Systems, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which standard of care treatment is the first listed.
NCT01208142 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01208142 about?
NCT01208142 is a clinical study titled "Toe Walker Gait Trial". The purpose of this study is to examine the change in ankle plantar flexion while walking, following treatment with the Ankle Dorsiflexion Dynasplint (AFD) for children diagnosed as Toe Walkers. For twelve weeks, patients will either receive the standard treatment or the same standard treatment and...
What is the current status of trial NCT01208142?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2010-09.
What interventions are being tested in trial NCT01208142?
The interventions under investigation include: standard of care treatment (OTHER), Ankle Flexion Dynasplint (DEVICE).
Who is sponsoring clinical trial NCT01208142?
This trial is sponsored by Dynasplint Systems, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.